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CD8þ Granzyme Bþ–Mediated Tissue Injury versus CD4þ IFNcþ–Mediated Parasite Killing in Human Cutaneous Leishmaniasis
Claire da Silva Santos, Viviane Boaventura, Cristina Ribeiro Cardoso, Natalia Tavares, Morgana J. Lordelo,
Alme´rio Noronha, Jackson Costa, Vale´ria M. Borges, Camila I. de Oliveira, Johan Van Weyenbergh,
Aldina Barral, Manoel Barral-Netto and Cla´udia Ida Brodskyn
Journal of Investigative Dermatology (2014) 134, 2850; doi:10.1038/jid.2014.230; published online 19 June 2014
Correction to: J Invest Dermatol (2013) 133:1533–1540; doi:10.1038/jid.2013.4; published online 14 February 2013
Following the publication of the article, the authors noted a missing affiliation for Johan Van Weyenbergh, who, in addition to
the affiliations stated in the article, is also affiliated with Rega Institute for Medical Research, Department of Microbiology and
Immunology, KU Leuven, Belgium. The authors regret the error.
Flt3L Dependence Helps Define an Uncharacterized Subset of Murine Cutaneous Dendritic Cells
Shamim A. Mollah, Joseph S. Dobrin, Rachel E. Feder, Sze-Wah Tse, Ines G. Matos, Cheolho Cheong,
Ralph M. Steinman and Niroshana Anandasabapathy
Journal of Investigative Dermatology (2014) 134, 2850–2851; doi:10.1038/jid.2014.234; published online 10 July 2014
Correction to: Journal of Investigative Dermatology (2014) 134, 1265–1275; doi:10.1038/jid.2013.515; published online
16 January 2014
Following the publication of this article, the authors noted an error in Sze-Wah Tse’s affiliation. The correct affiliation is number 5:
Department of Dermatology/Harvard Skin Disease Research Center, Brigham and Women’s Hospital, Boston, Massachusetts, USA.
In addition, panels d and e of Figure 1, panel b of Figure 4, and panel a of Figure 5 were misprinted. The correct versions of these
panels appear below:
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Figure 1. Flt3L dependence of migratory dendritic cell (DC) subsets, including Langerin–CD11b DCs. (d) Flt3L-induced expansion of skin-resident
DC subsets from ‘‘crawlout’’ skin explants of doxycycline-inducible Flt3L mice given 8 days of doxycycline in their drinking water (top) versus untreated controls
(bottom) (one representative experiment of two). (e) Quantification of DCs isolated from skin explant ‘‘crawlouts’’ of Flt3L-treated versus control Langerin
GFP reporter mice (pooled from the ears of three mice per experiment, one representative experiment of three).
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